Zhejiang Hisun Pharmaceutical Co.,Ltd. (China)

Zhejiang Hisun Pharmaceutical Co., Ltd. was reorganized as a joint stock limited company in 1998, on the basis of Zhejiang Haimen Pharmaceutical Plant. The promoters to the establishment of the company are Zhejian Haizheng Group Ltd., Sanlong Investment (Group ) Ltd., State Pharmaceutical Administer Bureau Shanghai Pharmaceutical Industry Research Institute, State Pharmaceutical Administer Bureau Sichuan Antibiotics Industry Research Institute, China Medical University, Zhejiang Medicine Industry Co., Guotou Pharmaceutical Investment Ltd. and Surgeon University No. 2 Zhaohui Pharmaceutical Plant. The company’s A shares were listed on Shanghai Stock Exchange on July 25, 2000. The company is principally engaged in the manufacture and distribution of pharmaceuticals. Its products include antineoplastic drugs, cardiovascular drugs, anti-infection drugs, endocrine control drugs, anti-parasite drugs, as well as animal remedies, among others. The company distributes its products under the brand name of HISUN. The company distributes its products in domestic markets and to overseas markets. As of December 31, 2010, the company had seven major subsidiaries and associates, which involved in the production of pharmaceuticals, technology research and the manufacture of containers.